Eterna Therapeutics Inc. Price to FCF Ratio 2006–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Eterna Therapeutics Inc. (ERNA): market cap divided by trailing twelve-month free cash flow. As of September 30, 2020 it is 171820.93.

From: 06/30/2011To: 09/30/2024

Stock Price

TTM Free Cash Flow

Price to FCF

Eterna Therapeutics Inc. Price to FCF Ratio — FAQ

Eterna Therapeutics Inc. (ERNA) price to fcf ratio over the last 14 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ERNA's price to fcf ratio history?

The chart and table above show Eterna Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.